Skip to main content
. 2023 Jul 3;26(8):107272. doi: 10.1016/j.isci.2023.107272

Figure 4.

Figure 4

In vitro anti-tumor cytotoxicity analysis of ICAM1-ADCs

(A) Schematic illustration and chemical structures of ICAM1-ADC linkers and warheads.

(B–F) in vitro cell growth inhibitory activity in BCPAP(B), IHH4(C), 8505C(D), TCO1(E), and 293T cell (F), The cells were treated with ICAM1 antibody, I1-MMAE, I1-DXd paclitaxel and vemurafenib (in BRAF mutation cells). Each point represents the mean and SD (n = 3).